Primary Care Clinics in Hazle Township, PA Accepting Medicare
9 Primary Care Clinics found. Showing 1 - 9
 Endocrinology Clinic P.c. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1090 N Church St, 200 Hazleton Professional Plaza, Hazle Township, PA 18202 Phone: 570-455-0100 Fax: 570-455-0177 |
Northeast Gastroenterology Center, Inc. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 10 Park Pl, Hazle Township, PA 18202 Phone: 570-454-1400 Fax: 570-454-2144 |
Evernorth Direct Health Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 600 Oak Ridge Rd, Hazle Township, PA 18202 Phone: 623-277-1190 |
Greater Hazleton Gastroenterology, P.c. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 10 Park Pl, Hazle Township, PA 18202 Phone: 570-617-6224 Fax: 570-454-2144 |
Northeast Counseling Services Clinic/Center Medicare: Medicare Enrolled Practice Location: 1700 W 22nd St, Hazle Township, PA 18202 Phone: 570-455-6385 |
Lehigh Valley Physician Group Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 50 Moisey Dr Ste 101, Hazle Township, PA 18202 Phone: 570-459-2226 |
Lehigh Valley Physician Group Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 26 Station Cir, Hazle Township, PA 18202 Phone: 570-861-8717 |
St. Luke's Hazleton Primary Care Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1097 N Church St, Hazle Township, PA 18202 Phone: 484-526-4000 Fax: 833-213-6428 |
Caring Community Health Center Family Medicine - Adult Medicine Medicare: Medicare Enrolled Practice Location: 426 Airport Rd, Hazle Township, PA 18202 Phone: 570-459-9730 |
News Archive
Discovery of dual role played by PGK1 enzyme may indicate new therapeutic target for brain cancer
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria
The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.
Novel method for estimating the ability of SARS-CoV-2 to spread in a population
Researchers from Curtin University have formulated a new modeling framework to help identify the transmissibility of COVID-19 based on periods of varying case incidence.
Grassley to introduce bill modifying how 'not-for-profit' hospitals set executive pay
Senate Finance Committee ranking member Chuck Grassley (R-Iowa) on Tuesday said that he intends to introduce legislation that would increase pressure on the boards of directors at not-for-profit hospitals to ensure pay for the facilities' presidents is reasonable, the Boston Globe reports.
Medivir reports 2009 financial results
Medivir had a very satisfactory 2009. Our cold sore product secured market approval in the US and Europe and is well positioned for launch. This will take place under the XerclearTM trademark in Europe, and under the XereseTM trademark in the US during 2010.
› Verified 8 days ago